ReviewGut2019
International consensus conference on stool banking for faecal microbiota transplantation in clinical practice.
7 registry-linked trialsAbstract readReviewConsensus Statement
In one paragraph
Review in Gut, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 7 registered trials, which are not on this map. Cited by 282 papers, 8 of them syntheses that pooled it.
0numbers the graph read from it
0cells of the map it votes in
282citing papers in PubMed, 8 pooled it
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
NCT04758507 phase1 / phase2completednot on this mapstarted 2021, after this paper: background citation
Targeting Gut Microbiota to Improve Efficacy of Immune Checkpoint Inhibitors in Patients With Advanced Renal Cell Carcinoma
NCT04759001 phase1 / phase2recruitingnot on this mapstarted 2021, after this paper: background citation
Faecal Microbiota Transplantation to Eradicate Gut Colonisation From Carbapenem-resistant Enterobacteriaceae: a Randomised Controlled Trial
Lyophilized Fecal Microbiome Transfer for Primary Clostridioides Difficile Infection (DONATE Study): a Multicenter Randomized Controlled Trial
NCT05917379 phase1 / phase2completednot on this mapstarted 2023, after this paper: background citation
The Safety and Efficacy of Fecal Microbiota Transplantation in Patients With Chronic Insomnia Disorder
Washed Microbiota Transplantation for Clostridioides Difficile Infection: a Real World Research
NCT06836427 early_phase1not yet recruitingnot on this mapstarted 2025, after this paper: background citation
CMTS0929 for Clostridioides Difficile Infection: a Prospective, Open-label, Single-arm Clinical Study
Disentangling Microbiome Engraftment by Multi-omics of the Gut Ecosystem During Fecal Transplant
Who cites it
282 citing papers in PubMed, 8 syntheses or guidelines pooled it.
- Functional convergence amid taxonomic variability in gut microbiome-immune checkpoint inhibitor research: a bibliometric and mechanistic synthesis.Frontiers in immunology · 2026Pooled it
- Mapping research trends in irritable bowel syndrome and the gut microbiome: a cross-database bibliometric analysis.Frontiers in microbiology · 2026Pooled it
- Clinical efficacy and safety of faecal microbiota transplantation in the treatment of irritable bowel syndrome: a systematic review, meta-analysis and trial sequential analysis.European journal of medical research · 2024Pooled it
- Fecal microbiota transplantation for the treatment of irritable bowel syndrome: A systematic review and meta-analysis.World journal of gastroenterology · 2023Pooled it
- Fecal microbiota transplantation for irritable bowel syndrome: a systematic review and meta-analysis of randomized controlled trials.Frontiers in immunology · 2023Pooled it
- Variability of strain engraftment and predictability of microbiome composition after fecal microbiota transplantation across different diseases.Nature medicine · 2022Pooled it
- Encyclopedia of fecal microbiota transplantation: a review of effectiveness in the treatment of 85 diseases.Chinese medical journal · 2022Pooled it
- Fecal microbiota transplantation in irritable bowel syndrome: A meta-analysis of randomized controlled trials.Frontiers in medicine · 2022Pooled it
- Safety and efficacy of fecal microbiota transplantation in solid cancers resistant to immune checkpoint inhibitors: results of the MITRIC trial.Journal for immunotherapy of cancer · 2026Trial
- Trial
- Fecal microbiota transplantation plus pembrolizumab and axitinib in metastatic renal cell carcinoma: the randomized phase 2 TACITO trial.Nature medicine · 2026Trial
- Trial
- Transient colonization with Blastocystis spp. after transmission via fecal microbiota transplantation.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2025Trial
- Novel Microbial Engraftment Trajectories Following Microbiota Transplant Therapy in Ulcerative Colitis.Journal of Crohn's & colitis · 2025Trial
- Colonic distribution of FMT by different enema procedures compared to colonoscopy - proof of concept study using contrast fluid.BMC gastroenterology · 2023Trial
- Use of Faecal Transplantation with a Novel Diet for Mild to Moderate Active Ulcerative Colitis: The CRAFT UC Randomised Controlled Trial.Journal of Crohn's & colitis · 2022Trial
- Fecal Microbiota Transplantation BeyondJournal of Korean medical science · 2026Review
- Gut microbiome dynamics in acute infectious diarrhea: A conceptual framework from acute dysbiosis toward precision restoration (Review).Experimental and therapeutic medicine · 2026Review
- Fecal Microbiota Transplantation and Microbiota-Based Therapeutics in Allogeneic Hematopoietic Stem Cell Transplantation: Current Evidence and Future Directions.Clinical pharmacology and therapeutics · 2026Review
- Acute Tolerability and Long-Term Surveillance of Fecal Microbiota Transplantation in Children with Autism: A Real-World Study of 604 Procedures.Advances in therapy · 2026Article
222 more citing papers are in PubMed but not listed here.
Corrections and comments
- Commented on by
Authors and funding
29 authors.
Giovanni CammarotaInternal Medicine and Gastroenterology, Day Hospital of Gastroenterology and Intestinal Microbiota Transplantation, Fondazione Policlinico A Gemelli IRCCS, Catholic University of Medicine, Roma, Italy giovanni.cammarota@unicatt.it.ORCID 0000-0002-3626-6148
Gianluca IaniroInternal Medicine and Gastroenterology, Day Hospital of Gastroenterology and Intestinal Microbiota Transplantation, Fondazione Policlinico A Gemelli IRCCS, Roma, Italy.
Colleen R KellyDivision of Gastroenterology, Alpert Medical School of Brown University, Providence, Rhode Island, United States of America.
Benjamin H MullishDepartment of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London, London, United Kingdom.ORCID 0000-0001-6300-3100
Jessica R AllegrettiDivision of Gastroenterology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America.
Zain KassamMicrobiome Informatics, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America.
Lorenza PutignaniParasitology Unit and Human Microbiome Unit, Bambino Gesù Pediatric Hospital, Roma, Italy.
Monika FischerDepartment of Medicine, Indiana University, Indianapolis, Indiana, United States of America.
Josbert J KellerDepartment of Gastroenterologyand Hepatology, Haaglanden Medical Center, 2597 AX, The Hague, Netherlands.
Samuel Paul CostelloDepartment of Gastroenterology, The Queen Elizabeth Hospital, University of Adelaide, Woodville, South Australia, Australia.
Harry SokolService de Gastroenterologie, Hôpital Saint Antoine, Sorbonne Université, Inserm, Centre de Recherche Saint-Antoine, Paris, France.
Patrizia KumpDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
Reetta SatokariHuman Microbiome Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Stacy A KahnDivision of Gastroenterology, Hepatology and Nutrition, Boston Children's Hospital, Boston, Massachusetts, Uunited States of America.
Dina KaoDivision of Gastroenterology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada.
Perttu ArkkilaDepartment of Clinic of Gastroenterology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Ed J KuijperDepartment of Medical Microbiology, Leiden University Medical Centre, Leiden, the Netherlands.
Maria J Gt VehreschildDepartment I of Internal Medicine; German Centre for Infection Research, Partner site Bonn-Cologne, University Hospital of Cologne, Cologne, Germany.
Cristina PintusTissues and Cells Area, Italian National Transplant Center, Rome, Italy.
Loris LopetusoInternal Medicine and Gastroenterology, Fondazione Policlinico A Gemelli IRCCS, Roma, Italy.
Luca MasucciMicrobiology, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Catholic University of Medicine, Roma, Italy.
Franco ScaldaferriInternal Medicine and Gastroenterology, Fondazione Policlinico A Gemelli IRCCS, Roma, Italy.
E M TerveerNational Donor Feces Bank, LUMC, Leiden, the Netherlands.
Max NieuwdorpDepartment of Internal Medicine, Amsterdam University Medical Centers, location AMC and VuMC, Amsterdam, Netherlands.
Antonio López-SanrománGastroenterology and Hepatology Department, Hospital Universitario Ramon y Cajal, Madrid, Spain.
Juozas KupcinskasDepartment of Gastroenterology, Institute for Digestive Research, Medical Academy, Lithuanian University of Health Sciences, Kaunas, Lithuania.
Ailsa HartDepartment of Gastroenterology, St Mark's Hospital, London, United Kingdom.
Herbert TilgDepartment of Internal Medicine I, Gastroenterology, Endocrinology & Metabolism, Innsbruck Medical University, Innsbruck, Austria.
Antonio GasbarriniInternal Medicine and Gastroenterology, Fondazione Policlinico A Gemelli IRCCS, Catholic University of Medicine, Roma, Italy.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Although faecal microbiota transplantation (FMT) has a well-established role in the treatment of recurrent
Indexed as
Gastrointestinal MicrobiomeClostridioides difficileClostridium InfectionsDonor SelectionFecal Microbiota TransplantationHumansSpecimen Handlingclostridioides difficilefecal microbiota transplantationguidelinemicrobiotastool bank
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC
Read underepoch 390
Registered trials
NCT04758507ClinicalTrials.gov
NCT04759001ClinicalTrials.gov
NCT05709184ClinicalTrials.gov
NCT05917379ClinicalTrials.gov
NCT06106698ClinicalTrials.gov
NCT06836427ClinicalTrials.gov
and 1 more above
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.